These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35643491)

  • 1. Patient perspectives on delays in cervical cancer screening and follow-up care in Botswana: a mixed methods study.
    Rendle KA; Ramogola-Masire D; Monare B; Ogden SN; Toneff HK; Saia CA; Wainwright JV; Friebel-Klingner TM; Bazzett-Matabele L; Bhatia R; Bonner N; Ralefala TB; Vuylsteke P; Luckett R; Grover S
    BMC Womens Health; 2022 May; 22(1):195. PubMed ID: 35643491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delays in Cervical Cancer Treatment Initiation for Patients Living With or Without HIV in Botswana: An Observational Cohort Analysis (2015-2019).
    George J; Tuli S; Patel PP; Monare B; Ramogola-Masire D; Bazzett-Matabele L; Bvochora-Nsingo M; Chiyapo S; Ralefala T; Vuylsteke P; Rendle KA; Grover S
    Int J Radiat Oncol Biol Phys; 2024 Aug; 119(5):1368-1378. PubMed ID: 38462016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to screening appointments in a cervical cancer clinic serving HIV-positive women in Botswana.
    Barchi F; Winter SC; Ketshogile FM; Ramogola-Masire D
    BMC Public Health; 2019 Mar; 19(1):318. PubMed ID: 30885175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana.
    Ramogola-Masire D; Grover S; Mathoma A; Monare B; Gabaitiri L; Bazzett-Matabele L; Hofmeyr G; Morroni C; Luckett R
    BMC Womens Health; 2022 Apr; 22(1):100. PubMed ID: 35366863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distance to Multidisciplinary Team Clinic in Gaborone, Botswana, and Stage at Cervical Cancer Presentation for Women Living With and Without HIV.
    Friebel-Klingner TM; Bazzett-Matabele L; Ramogola-Masire D; Monare B; Ralefala TB; Seiphetlheng A; Ramontshonyana G; Vuylsteke P; Mitra N; Wiebe DJ; Rebbeck TR; McCarthy AM; Grover S
    JCO Glob Oncol; 2022 Nov; 8():e2200183. PubMed ID: 36395437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to accessing cervical cancer screening among HIV positive women in Kgatleng district, Botswana: A qualitative study.
    Matenge TG; Mash B
    PLoS One; 2018; 13(10):e0205425. PubMed ID: 30356248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cancer screening services provided for people living with HIV in Botswana, 2022-2023.
    Mathoma A; Sartorius B; Mahomed S
    Health Promot Int; 2024 Jun; 39(3):. PubMed ID: 38742893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer awareness and screening in Botswana.
    Mingo AM; Panozzo CA; DiAngi YT; Smith JS; Steenhoff AP; Ramogola-Masire D; Brewer NT
    Int J Gynecol Cancer; 2012 May; 22(4):638-44. PubMed ID: 22367370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening in HIV-endemic countries: An urgent call for guideline change.
    Grover S; Bhatia R; Friebel-Klingner TM; Mathoma A; Vuylsteke P; Khan S; Ralefala T; Tawe L; Bazzett-Matabele L; Monare B; Luckett R; Ramogola-Masire D
    Cancer Treat Res Commun; 2023; 34():100682. PubMed ID: 36682141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.
    Mitchell SM; Pedersen HN; Eng Stime E; Sekikubo M; Moses E; Mwesigwa D; Biryabarema C; Christilaw J; Byamugisha JK; Money DM; Ogilvie GS
    BMC Womens Health; 2017 Jan; 17(1):4. PubMed ID: 28086933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana.
    Friebel-Klingner TM; Luckett R; Bazzett-Matabele L; Ralefala TB; Monare B; Nassali MN; Ramogola-Masire D; Bvochora M; Mitra N; Wiebe D; Rebbeck TR; McCarthy AM; Grover S
    BMC Womens Health; 2021 Jul; 21(1):267. PubMed ID: 34229672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV knowledge, screening barriers and facilitators, and sources of health information among women living with HIV: perspectives from the DC community during the COVID-19 pandemic.
    Ciceron AC; Jeon MJ; Monroe AK; Clausen ME; Magnus M; Le D
    BMC Womens Health; 2022 Apr; 22(1):110. PubMed ID: 35397535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of integration of cervical cancer screening into routine HIV care, associated factors and perceptions among HIV-infected women: a mixed methods study at Mbarara Regional Referral Hospital, Uganda.
    Ninsiima M; Nyabigambo A; Kagaayi J
    BMC Health Serv Res; 2023 Apr; 23(1):333. PubMed ID: 37013535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of cervical cancer screening and its associated factors among women of child-bearing age in Mangochi district, Malawi: a facility-based cross-sectional study.
    Mpachika-Mfipa F; Kululanga LI; Mfipa D; Kazembe A
    BMC Womens Health; 2023 Jun; 23(1):334. PubMed ID: 37355588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
    Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
    BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
    Meghani K; Puri P; Bazzett-Matabele L; Vuylsteke P; Luckett R; Monare B; Chiyapo S; Ketlametswe R; Ralefala TB; Bvochora-Nsingo M; Zetola N; Ramogola-Masire D; Grover S
    Cancer; 2024 Jul; 130(14):2462-2471. PubMed ID: 38529676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and Facilitators to Cervical Cancer Screening, Diagnosis, Follow-Up Care and Treatment: Perspectives of Human Immunodeficiency Virus-Positive Women and Health Care Practitioners in Tanzania.
    Bateman LB; Blakemore S; Koneru A; Mtesigwa T; McCree R; Lisovicz NF; Aris EA; Yuma S; Mwaiselage JD; Jolly PE
    Oncologist; 2019 Jan; 24(1):69-75. PubMed ID: 29934410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.
    Grover S; MacDuffie EC; Wang Q; Bvochora-Nsingo M; Bhatia RK; Balang D; Chiyapo SP; Luckett R; Ramogola-Masire D; Dryden-Peterson SL; Lin LL; Shin SS; Zetola NM
    Cancer; 2019 May; 125(10):1645-1653. PubMed ID: 30801696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
    Choi Y; Ibrahim S; Park LP; Cohen CR; Bukusi EA; Huchko MJ
    BMC Womens Health; 2022 Apr; 22(1):122. PubMed ID: 35436908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge and experience of a cohort of HIV-positive and HIV-negative Ghanaian women after undergoing human papillomavirus and cervical cancer screening.
    Stuart A; Obiri-Yeboah D; Adu-Sarkodie Y; Hayfron-Benjamin A; Akorsu AD; Mayaud P
    BMC Womens Health; 2019 Oct; 19(1):123. PubMed ID: 31647013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.